​

Zimmer Biomet (ZBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZBH Stock Forecast

Zimmer Biomet (ZBH) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $117.00, with a high of $117.00 and a low of $117.00. This represents a 19.49% increase from the last price of $97.92.

$95 $103 $111 $119 $127 $135 High: $117 Avg: $117 Low: $117 Last Closed Price: $97.92

ZBH Stock Rating

Zimmer Biomet stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 20 Buy (55.56%), 14 Hold (38.89%), 2 Sell (5.56%), and 0 Strong Sell (0.00%).

Buy
Total 36 0 2 14 20 Strong Sell Sell Hold Buy Strong Buy

ZBH Price Target Upside V Benchmarks

TypeNameUpside
StockZimmer Biomet19.49%
SectorHealthcare Stocks 35.94%
IndustryMedical Device Stocks21.01%

Price Target Trends

1M3M12M
# Anlaysts--15
Avg Price Target--$128.13
Last Closing Price$97.92$97.92$97.92
Upside/Downside--30.85%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2565171130
Mar, 2556171130
Feb, 2556171130
Jan, 2556171130
Dec, 2456181131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 31, 2024Richard NewitterTruist Financial$117.00$106.929.43%19.49%
Oct 15, 2024Steven LichtmanOppenheimer$135.00$104.8328.78%37.87%
Oct 03, 2024Ryan ZimmermanBTIG$126.00$105.6919.22%28.68%
Oct 01, 2024Vijay KumarEvercore ISI$110.00$107.951.90%12.34%
Sep 13, 2024Richard NewitterTruist Financial$112.00$105.146.52%14.38%
Sep 10, 2024Caitlin CroninCanaccord Genuity$115.00$104.839.70%17.44%
Aug 08, 2024Jayson BedfordRaymond James$128.00$107.0919.53%30.72%
Aug 08, 2024Steven LichtmanOppenheimer$145.00$105.8137.04%48.08%
Aug 07, 2024Rick WiseStifel Nicolaus$130.00$107.5020.93%32.76%
Jul 15, 2024Drew RanieriMorgan Stanley$120.00$108.6910.41%22.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 14, 2025BTIGBuyBuyhold
Oct 15, 2024OppenheimerOutperformOutperformhold
Oct 14, 2024William BlairBuyBuyhold
Oct 03, 2024BTIGBuyBuyhold
Oct 01, 2024Evercore ISIPositivePositivehold
Sep 17, 2024NeedhamHoldHoldhold
Sep 13, 2024Goldman SachsBuyBuyhold
Sep 10, 2024Canaccord GenuityHoldHoldhold
Sep 09, 2024Wolfe ResearchPeer Performinitialise
Sep 05, 2024UBSEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.66$1.93$1.39$4.91-----
Avg Forecast$5.46$7.17$6.84$7.51$7.98$8.56$9.24$9.99$10.61
High Forecast$5.55$7.28$6.90$7.57$8.01$8.82$11.87$10.76$10.73
Low Forecast$5.40$7.08$6.75$7.23$7.94$8.44$7.18$9.22$10.43
Surprise %-112.09%-73.08%-79.68%-34.62%-----

Revenue Forecast

$2B $4B $5B $7B $8B $10B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.02B$6.83B$6.94B$7.39B$2.02B----
Avg Forecast$7.02B$7.86B$6.87B$7.38B$7.67B$8.01B$8.38B$8.78B$9.19B
High Forecast$7.10B$7.95B$6.92B$7.43B$7.68B$8.08B$8.38B$8.81B$9.27B
Low Forecast$6.96B$7.79B$6.80B$7.24B$7.66B$7.92B$8.37B$8.76B$9.07B
Surprise %0.02%-13.16%0.95%0.16%-73.62%----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-137.40M$401.60M$231.40M$1.02B-----
Avg Forecast$-282.29M$368.25M$224.98M$1.02B$1.67B$1.81B$2.00B$2.10B$2.22B
High Forecast$-28.67M$475.67M$307.13M$1.40B$1.68B$1.85B$2.49B$2.26B$2.25B
Low Forecast$-535.92M$260.83M$142.84M$651.48M$1.67B$1.77B$1.50B$1.93B$2.19B
Surprise %-51.33%9.06%2.85%------

ZBH Forecast FAQ

Is Zimmer Biomet stock a buy?

Zimmer Biomet stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 20 Buy, 14 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Zimmer Biomet is a favorable investment for most analysts.

What is Zimmer Biomet's price target?

Zimmer Biomet's price target, set by 36 Wall Street analysts, averages $117 over the next 12 months. The price target range spans from $117 at the low end to $117 at the high end, suggesting a potential 19.49% change from the previous closing price of $97.92.

How does Zimmer Biomet stock forecast compare to its benchmarks?

Zimmer Biomet's stock forecast shows a 19.49% upside, underperforming the average forecast for the healthcare stocks sector (35.94%) and underperforming the medical device stocks industry (21.01%).

What is the breakdown of analyst ratings for Zimmer Biomet over the past three months?

  • April 2025: 20.00% Strong Buy, 16.67% Buy, 56.67% Hold, 3.33% Sell, 3.33% Strong Sell.
  • March 2025: 16.67% Strong Buy, 20.00% Buy, 56.67% Hold, 3.33% Sell, 3.33% Strong Sell.
  • February 2025: 16.67% Strong Buy, 20.00% Buy, 56.67% Hold, 3.33% Sell, 3.33% Strong Sell.

What is Zimmer Biomet’s EPS forecast?

Zimmer Biomet's average annual EPS forecast for its fiscal year ending in December 2025 is $8.56, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $9.24 in 2026, $9.99 in 2027, and $10.61 in 2028.

What is Zimmer Biomet’s revenue forecast?

Zimmer Biomet's average annual revenue forecast for its fiscal year ending in December 2025 is $8.01B, reflecting a 295.91% increase from the reported $2.02B in 2024. The forecast for 2026 is $8.38B, followed by $8.78B for 2027, and $9.19B for 2028.

What is Zimmer Biomet’s net income forecast?

Zimmer Biomet's net income forecast for the fiscal year ending in December 2025 stands at $1.81B, representing a 0% decrease from the reported $0 in 2024. Projections indicate $2B in 2026, $2.1B in 2027, and $2.22B in 2028.